Although we still do not know why hematological cancer cells are more vulnerable to PCLX-001 than other cancer cell types, we think this is possibly related to altered expression of either NMT1 or NMT2. The gene discussed is NMT1; the disease is hematopoietic and lymphoid cell neoplasm.